Podcast Series

Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making — among other topics.


2020 Episode 3 – Metformin: Is it Always First?
Listen to George L. Bakris, MD, FAHA, FASN, Cecilia C. Low Wang, MD, FACP and Neda Rasouli, MD educate clinicians on the updates made in the 2021 ADA Standards of Care related to metformin use and considerations for when the guideline recommends considering use of SGLT-2 inhibitors and GLP-1 receptor agonists independent of A1C or metformin use.
2021 Episode 2 – FAQs for Patients with Renal Disease, Heart Failure and Type 2 Diabetes
On our recent webinar on Renal Disease in Patients with Heart Failure and Diabetes, we took your questions and on this episode, we revisit some of the most frequently asked questions on managing renal disease in patients with heart failure and type 2 diabetes, with our guest, Dr. Robert Eckel.
2021 Episode 1 – American Diabetes Association’s 2021 Standards of Care and Implications for Practice
Listen to Dr. Boris Draznin, an endocrinologist and specialist in diabetes and internal medicine, and Dr. Pam Kushner, a specialist in family medicine discuss how the new American Diabetes Association’s 2021 Standards of Care have changed and implications for practice.
2020 Episode 10 – Managing CV and Renal Risk in Patients with T2D
Patients with T2D and CKD have a very high risk of CV events. Listen as Dr. Jorge Plutzky and Dr. Neha Pagidipati discuss new therapies to manage cardiovascular and renal risk in patients with T2D. Their discussion is based on new science presented during AHA Scientific Sessions 2020.
2020 Episode 9 – Health Disparities in Diagnosis and Treatment
Listen as Dr. Eduardo Sanchez from the American Heart Association and Dr. Robert Gabbay from the American Diabetes Association discuss social determinants of health and disparities in health and health care in individuals with type 2 diabetes at risk for cardiovascular disease and COVID-19 and what can be done to improve their outcomes.
2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD
Listen to leading experts discuss the new Scientific Statement from the American Heart Association, “Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease,” where two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.
T2D & CKD
Kidney Disease Resources Stay up to date with the latest news, research and scientific guidelines to help you reduce diabetes-related renal complications in patients living…
Read More
Webinar Series
Know Diabetes by Heart™ Professional Education Webinar Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist…
Read More
DSMES Services
Diabetes Self-Management Education and Support Services Diabetes self-management education and support (DSMES) services provide the foundation to help people with diabetes navigate their treatment goals…
Read More